DISINFORMATION CASE DETAILS
- Outlet: mehrbani.shafaqna.com ( archive, original ) , arabic.rt.com ( archive #1, archive #2, original ) , akhbarak.net ( archive, original ) , i3lnat.com ( archive, original ) , sahafaty.net ( archive, original ) , news-pop.com ( archive, original ) , asrar7.com ( archive, original ) , sahafaty.com ( archive, original ) , shaaeb.net ( archive, original ) , ar.albousla.ps ( archive, original ) , 6060news.com ( archive, original ) , kalimanews.net ( archive, original ) , almatareed.org ( archive, original ) , nafeza2world.com ( archive, original ) , wtani.com ( archive, original ) , rifress.com ( archive, original ) , nuomnews.com ( archive, original ) , alaan.org ( archive, original ) , orientbethlehem.net ( archive, original ) , waradana.com ( archive, original ) , beirut-news.com ( archive, original ) , kachaf.com ( archive, original ) , ruarab.top ( archive, original ) , mayadeeniraqya.com ( archive, original ) , alnassrnews.com ( archive, original )
- Date of publication: June 21, 2021
- Article language(s): Arabic
- Countries / regions discussed: Russia
AI translations:
DISINFO: Sputnik V is the most effective vaccine against the Indian Covid-19 variant
SUMMARY
The “Sputnik V” vaccine proves more effective than all other vaccines against the Indian COVID-19 variant
RESPONSE
This is a claim provided with no evidence, and constitutes a recurring attempt by pro-Kremlin outlets to promote the Russian Sputnik V vaccine.
The effectiveness of different vaccines against the COVID-19 Delta variants (referred to in the claim as the "Indian variant") is still subject to ongoing monitoring due to the relatively news appearance. However, preliminary analysis conducted by researchers from Imperial College London, Oxford University, the UK NHS, among others, demonstrates that established vaccines have been proven to be effective against the Delta variants with comparable results to the original Alpha variant.
For example, the Pfizer-BioNTech vaccine was found to be 96% effective against hospitalisation after two doses, while the Oxford-AstraZeneca vaccine was found to be 92% effective against hospitalisation after the second dose. On the other hand, Sputnik V's effectiveness against the Delta variants was found by its own developers to be less than against other varieties (90% versus 92%), as reported by the Russian TASS news agency.